top of page

The SPIRIT–CONSORT Group

The SPIRIT-CONSORT Group is an international and eclectic group, comprising trialists, methodologists, journal editors and most recently patient representatives. Just as the SPIRIT and CONSORT Statements are tools that evolve in response to the emerging evidence, the membership of the SPIRIT–CONSORT Group is dynamic, evolving in response to emerging projects and needed expertise.

Funding

SPIRIT and CONSORT receive some limited funding to support, coordination and research work. This funding is greatly appreciated by the SPIRIT–CONSORT Group, and has enabled some aspects of the work to be funded that were never before formally supported. 

The history of CONSORT funding is as follows:
•    Medical Research Council–National Institute for Health and Care Research, UK (2022–2024, Better Methods,

     Better Research [MR/W020483/1])
•    Medical Research Council, UK (2006–2015)
•    US National Library of Medicine (1999–2004)

The history of SPIRIT funding is as follows:

•    Medical Research Council–National Institute for Health and Care Research, UK (2022–2024, Better Methods,

     Better Research [MR/W020483/1])
•    Canadian Institutes of Health Research
               - Dissemination Events grant (2012–13, Ethics MET-117434)
               - Dissemination Events grant (2010, Ethics DET-106068)
               - Workshop grant (2007)
•    Canadian Agency for Drugs and Technologies in Health
               - Workshop grant (2009)    
•    National Cancer Institute of Canada
               - Workshop grant (2007)
•    Women’s College Hospital, Canada
               - In-kind support (2009–present)

In addition, we gratefully acknowledge these organisations and individuals for their financial support of the following CONSORT activities:

CONSORT Group Meeting 2011
•    President’s Fund – Canadian Institutes of Health Research
•    Johnson & Johnson
•    Pfizer USA
•    AstraZeneca
•    GlaxoSmithKline

​

CONSORT Group Meeting 2007
•    UK National Co-ordinating Centre for Research Methodology
•    American Society of Clinical Oncology
•    Canadian Institutes of Health Research
•    Johnson & Johnson
•    BMJ
•    UK Cochrane Centre
•    Nordic Cochrane Centre
•    The Lancet
•    PLoS Medicine

CONSORT Group Meetings 1999 and 2000
•    Abbott Laboratories
•    American College of Physicians/American 

      Society of Internal Medicine
•    GlaxoWellcome, Inc. (now part of SmithKline

      Beecham, Inc.)
•    The Lancet
•    Merck & Co., Inc.
•    Canadian Institutes of Health Research
•    US National Library of Medicine 
•    TAP Pharmaceutical Products, Inc.
•    BMJ
•    Council of Science Editors
•    International Committee of Medical Journal

     Editors (Vancouver Group)
 

Logo: jointly funded by the UKRI Medical Research Council and the NIHR (National Institute for Health and Care Research)
University of Oxford logo
University of Toronto logo
The University of North Carolina at Chapel Hill logo
University of Southern Denmark (SDU) logo
University of Ottawa (uOttawa) logo
Université Paris Cité (UPC) logo

The 2025 update of SPIRIT and CONSORT, and this website, are funded by the MRC-NIHR: Better Methods, Better Research [MR/W020483/1]. The views expressed are those of the authors and not necessarily those of the NIHR, the MRC, or the Department of Health and Social Care.

bottom of page